Rheumatology

Sarcoidosis

Questions discussed in this category

Do you utilize soluble IL-2 receptor or ACE levels as serum biomarkers to monitor disease activity in pulmonary sarcoidosis?

1 Answer available

Do you continue methotrexate while starting TNFi therapy in patients with refractory pulmonary sarcoidosis?

3 Answers available

How do you treat patients with sarcoid who have persistent symptoms after an initial 6 week course of corticosteroids?

3 Answers available

How do you treat multisystem sarcoidosis refractory to methotrexate, humira, and remicade?

2 Answers available

How would you approach asymptomatic hepatic sarcoid?

Multiple lesions on PET

1 Answer available

What is your approach for disease activity monitoring in patients with sarcoidosis?

1 Answer available

What steroid sparing agent do you use for treatment of cardiac sarcoidosis?

Does the type of cardiac involvement impact this choice?

2 Answers available

How do you assess transaminitis in a patient with sarcoidosis with known liver involvement being treated with methotrexate?

1 Answer available

What steroid-sparing agent would you use for treatment of neurosarcoidosis with leptomeningeal and parenchymal involvement?

1 Answer available

How do you manage calcium and vitamin D supplementation in patients with sarcoidosis on chronic steroids?

1 Answer available

Papers discussed in this category

Neurology, 2016 Nov 16

Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil.

Clin. Chest Med., 2015 Sep 26

Neurosarcoidosis.

Clin. Exp. Rheumatol., 2013 Dec 09

Anti-TNF-α therapy in the management of severe neurosarcoidosis: a report of five cases from a single centre and literature review.

Semin Arthritis Rheum, 2020 Jun

TNF-alpha inhibition for the treatment of cardiac sarcoidosis.

Intern Med, 2014 Dec 01

Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions.

J Am Heart Assoc, 2019 Sep 06

Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.

Clin Rheumatol, 2007 Mar 30

Cardiac sarcoidosis responding to monotherapy with infliximab.

Respir Med, 2012 Apr 09

The treatment of pulmonary sarcoidosis.

Am J Respir Crit Care Med,

Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Seminars in respiratory and critical care medicine, 2002-12

Hepatic, splenic, and gastrointestinal involvement with sarcoidosis.

Clinics in liver disease, 2019-05

Sarcoidosis and the Liver.

Eur J Gastroenterol Hepatol,

Natural history of hepatic sarcoidosis and its response to treatment.

Neth J Med,

Sarcoidosis of the liver: to treat or not to treat?

Semin Respir Crit Care Med, 2020 Aug 10

Hepatic Sarcoidosis: Current Concepts and Treatments.

The European respiratory journal, 2014-11

Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis.

Clin Exp Rheumatol, 2019 Nov 20

Use of third-line therapies in advanced sarcoidosis.

N Engl J Med,

Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis.

Lung, 2021 Apr 07

Tofacitinib as a Steroid-Sparing Therapy in Pulmonary Sarcoidosis, an Open-Label Prospective Proof-of-Concept Study.

Drugs,

Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.

Eur Respir J, 2021 Dec 16

ERS clinical practice guidelines on treatment of sarcoidosis.

Rheumatology

Sarcoidosis

Questions discussed in this category

Papers discussed in this category

Related Topics in Rheumatology